Filing Details
- Accession Number:
- 0001103021-20-000156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 16:39:39
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 16:39:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1757833 | James Vollins | C/O Biodelivery Sciences Intl, Inc. 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-14 | 20,320 | $3.46 | 20,320 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-14 | 20,320 | $4.46 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-16 | 9,505 | $3.46 | 9,505 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-16 | 9,505 | $4.48 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2020-12-14 | 20,320 | $3.46 | 20,320 | $3.46 |
| Common Stock | Stock Options (right to buy) | Disposition | 2020-12-16 | 9,505 | $3.46 | 9,505 | $3.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,331 | 2028-11-05 | No | 4 | M | Direct | |
| 29,826 | 2028-11-05 | No | 4 | M | Direct |
Footnotes
- The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's Common Stock for the 30-day period preceding November 5, 2018.
- The stock options were issued to the Reporting Person on November 5, 2018, pursuant to a grant under the Company's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and the remaining amount will vest November 5, 2021.
Billionaire Hedge Funds
